Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.850
-0.050 (-2.63%)
At close: Mar 6, 2026, 4:00 PM EST
1.940
+0.090 (4.86%)
After-hours: Mar 6, 2026, 7:52 PM EST
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $4.15 million as of March 6, 2026. Its market cap has decreased by -61.85% in one year.
Market Cap
4.15M
Enterprise Value
-1.67M
1-Year Change
-61.85%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has decreased from $47.95M to $4.15M, a decrease of -91.35%. That is a compound annual growth rate of -41.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.15M | -18.60% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silexion Therapeutics | 5.25M |
| MetaVia | 5.17M |
| VivoSim Labs | 4.88M |
| Genprex | 4.80M |
| Silo Pharma | 4.79M |
| Bio Green Med Solution | 4.70M |
| BioRestorative Therapies | 4.66M |
| GeoVax Labs | 4.49M |